[1]
F. Damayanti, E. Darmawan, and S. Didik, “Cost-effectiveness of esomeprazole and pantoprazole as prophylaxis stress-related mucosal disease therapy in Intensive Care Unit ”, Farmasains. J. Farm. Il. kes., vol. 6, no. 1, pp. 43–48, Oct. 2021.